Episode # 311 • 23 Jun 2026
Career Diversification for Urologists Beyond the Clinic
What happens when urologists look beyond the clinic and take on leadership in the life sciences industry? In this episode of BackTable Urology, host Dr. Raj Pruthi talks with Dr. Kelly Parsons and Dr. Pat Keegan about their journeys from academic urology to executive roles in biotech and pharma. They discuss what motivated their transitions, how physician expertise adds value in industry, and the realities of life outside of traditional clinical practice.
Timestamps
00:00 - Introduction
05:36 - Choosing a Non-Clinical Path
11:07 - Reactions from Mentors and Peers
14:31 - What Feels Most Fulfilling
18:31 - A Typical Week in Biotech
26:04 - Working with Investors
31:21 - Additional Degrees and MBA Debate
35:31 - Is it Risky to Leave Clinical Practice?
44:13 - Networking and Next Steps
47:59 - Wrap Up
You may also like
More about this episode
The conversation explores the day-to-day work of industry leaders, the impact of advanced degrees like MBAs, and the importance of networking for physicians considering a nonclinical path. Drs. Parsons and Keegan reflect on the challenges and rewards of leaving clinical medicine, the support and reactions from mentors and peers, and what they miss most about patient care. They also share practical advice for urologists and other specialists who are curious about new career opportunities beyond the exam room.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.